Characteristic | cCMV90 cohort N (%) | “Representative” controls N (%) | cCMV21-S cohort N (%) | “Healthy” controls N (%) |
---|---|---|---|---|
Observability | ||||
1–365 days of life | 54 (100.0) | 3240 (100.0) | 24 (100.0) | 1440 (100.0) |
366–730 days of life | 34 (63.0) | 2040 (63.0) | 15 (62.5) | 900 (62.5) |
Gender | ||||
Male | 30 (55.6) | 1,800 (55.6) | 15 (62.5) | 900 (62.5) |
Female | 24 (44.4) | 1,440 (44.4) | 9 (37.5) | 540 (37.5) |
Birth quarter | ||||
Q1 | 11 (20.4) | 660 (20.4) | 6 (25.0) | 360 (25.0) |
Q2 | 14 (25.9) | 840 (25.9) | 7 (29.2) | 420 (29.2) |
Q3 | 14 (25.9) | 840 (25.9) | < 5 (-) | 180 (12.5) |
Q4 | 15 (27.8) | 900 (27.8) | 8 (33.3) | 480 (33.3) |
Birth weight | ||||
Extremely low (P07.0–) | < 5 (–) | 11 (0.3) | < 5 (–) | 0 (0.0) |
Low (P07.1–) | 14 (25.9) | 128 (4.0) | 12 (50.0) | 0 (0.0) |
High (P08.1 or P08.2) | 0 (0.0) | 19 (0.6) | 0 (0.0) | 0 (0.0) |
Normal (infants with none of the stated codes) | 37 (68.5) | 3082 (95.1) | 9 (37.5) | 1440 (100.0) |
Region | ||||
Northb | 10 (18.5) | 574 (17.7) | < 5 (–) | 240 (16.7) |
Eastc | 9 (16.7) | 343 (10.6) | 7 (29.2) | 119 (8.3) |
Westd | 21 (38.9) | 1171 (36.1) | 8 (33.3) | 520 (36.1) |
Southe | 14 (25.9) | 1145 (35.3) | 7 (29.2) | 560 (38.9) |
Unknown | 0 (0.0) | 7 (0.2) | 0 (0.0) | < 5 (–) |